280 related articles for article (PubMed ID: 26955766)
21. The association between hypertensive disorders of pregnancy and abnormal second-trimester maternal serum levels of hCG and alpha-fetoprotein.
Morssink LP; Heringa MP; Beekhuis JR; De Wolf BT; Mantingh A
Obstet Gynecol; 1997 May; 89(5 Pt 1):666-70. PubMed ID: 9166297
[TBL] [Abstract][Full Text] [Related]
22. Serum hyperglycosylated human chorionic gonadotrophin at 14-17 weeks of gestation does not predict preeclampsia.
Keikkala E; Ranta JK; Vuorela P; Leinonen R; Laivuori H; Väisänen S; Marttala J; Romppanen J; Pulkki K; Stenman UH; Heinonen S
Prenat Diagn; 2014 Jul; 34(7):699-705. PubMed ID: 24464955
[TBL] [Abstract][Full Text] [Related]
23. The association between unexplained second-trimester maternal serum hCG elevation and pregnancy complications.
Gonen R; Perez R; David M; Dar H; Merksamer R; Sharf M
Obstet Gynecol; 1992 Jul; 80(1):83-6. PubMed ID: 1603504
[TBL] [Abstract][Full Text] [Related]
24. Elevated second-trimester maternal serum hCG alone or in combination with elevated alpha-fetoprotein.
Benn PA; Horne D; Briganti S; Rodis JF; Clive JM
Obstet Gynecol; 1996 Feb; 87(2):217-22. PubMed ID: 8559527
[TBL] [Abstract][Full Text] [Related]
25. Human chorionic gonadotropin, angiogenic factors, and preeclampsia risk: a nested case-control study.
Asvold BO; Eskild A; Vatten LJ
Acta Obstet Gynecol Scand; 2014 May; 93(5):454-62. PubMed ID: 24575980
[TBL] [Abstract][Full Text] [Related]
26. The value of elevated second-trimester beta-human chorionic gonadotropin in predicting development of preeclampsia.
Ashour AM; Lieberman ES; Haug LE; Repke JT
Am J Obstet Gynecol; 1997 Feb; 176(2):438-42. PubMed ID: 9065195
[TBL] [Abstract][Full Text] [Related]
27. First-trimester combined screening for trisomy 21 with different combinations of placental growth factor, free β-human chorionic gonadotropin and pregnancy-associated plasma protein-A.
Kagan KO; Hoopmann M; Abele H; Alkier R; Lüthgens K
Ultrasound Obstet Gynecol; 2012 Nov; 40(5):530-5. PubMed ID: 22611005
[TBL] [Abstract][Full Text] [Related]
28. The association of triple-marker test results with adverse pregnancy outcomes in low-risk pregnancies with healthy newborns.
Sayin NC; Canda MT; Ahmet N; Arda S; Süt N; Varol FG
Arch Gynecol Obstet; 2008 Jan; 277(1):47-53. PubMed ID: 17653738
[TBL] [Abstract][Full Text] [Related]
29. Maternal serum activin, inhibin, human chorionic gonadotrophin and alpha-fetoprotein as second trimester predictors of pre-eclampsia.
Davidson EJ; Riley SC; Roberts SA; Shearing CH; Groome NP; Martin CW
BJOG; 2003 Jan; 110(1):46-52. PubMed ID: 12504935
[TBL] [Abstract][Full Text] [Related]
30. Abnormal second-trimester serum analytes are more predictive of preterm preeclampsia.
Olsen RN; Woelkers D; Dunsmoor-Su R; Lacoursiere DY
Am J Obstet Gynecol; 2012 Sep; 207(3):228.e1-7. PubMed ID: 22818876
[TBL] [Abstract][Full Text] [Related]
31. Prediction of preeclampsia or intrauterine growth restriction by second trimester serum screening and uterine Doppler velocimetry.
Audibert F; Benchimol Y; Benattar C; Champagne C; Frydman R
Fetal Diagn Ther; 2005; 20(1):48-53. PubMed ID: 15608460
[TBL] [Abstract][Full Text] [Related]
32. The association between maternal serum first trimester free βhCG, second trimester intact hCG levels and foetal growth restriction and preeclampsia.
Sharony R; Sharon-Weiner M; Kidron D; Sukenik-Halevy R; Biron-Shental T; Manor M; Reinstein E; Maymon R
J Obstet Gynaecol; 2018 Apr; 38(3):363-366. PubMed ID: 29385871
[TBL] [Abstract][Full Text] [Related]
33. Pregnancy outcome and placental findings in pregnancies complicated by fetal growth restriction with and without preeclampsia.
Kovo M; Schreiber L; Elyashiv O; Ben-Haroush A; Abraham G; Bar J
Reprod Sci; 2015 Mar; 22(3):316-21. PubMed ID: 25001023
[TBL] [Abstract][Full Text] [Related]
34. Second-trimester levels of maternal serum human chorionic gonadotropin and inhibin a as predictors of preeclampsia in the third trimester of pregnancy.
Lambert-Messerlian GM; Silver HM; Petraglia F; Luisi S; Pezzani I; Maybruck WM; Hogge WA; Hanley-Yanez K; Roberts JM; Neveux LM; Canick JA
J Soc Gynecol Investig; 2000; 7(3):170-4. PubMed ID: 10865185
[TBL] [Abstract][Full Text] [Related]
35. [Pregnancy complications with abnormal results of biochemical screening for Down syndrome in second trimester and normal fetal karyotype].
Dimitrova V; Chernev T; Vragaleva S; Slŭncheva B; Mikhaĭlova E; Kremenski I; Simeonov E
Akush Ginekol (Sofiia); 2002; 41(6):3-12. PubMed ID: 12577497
[TBL] [Abstract][Full Text] [Related]
36. Unexplained elevated midtrimester maternal serum levels of alpha fetoprotein, human chorionic gonadotropin, or low unconjugated estriol: recurrence risk and association with adverse perinatal outcome.
Wax JR; Lopes AM; Benn PA; Lerer T; Steinfeld JD; Ingardia CJ
J Matern Fetal Med; 2000; 9(3):161-4. PubMed ID: 10914623
[TBL] [Abstract][Full Text] [Related]
37. Mid-trimester triple test levels in early and late onset severe pre-eclampsia.
Shenhav S; Gemer O; Sassoon E; Volodarsky M; Peled R; Segal S
Prenat Diagn; 2002 Jul; 22(7):579-82. PubMed ID: 12124692
[TBL] [Abstract][Full Text] [Related]
38. 2nd-trimester maternal serum human chorionic gonadotropin and alpha-fetoprotein levels in male and female fetuses with Down syndrome.
Lehavi O; Aizenstein O; Evans MI; Yaron Y
Fetal Diagn Ther; 2005; 20(3):235-8. PubMed ID: 15824504
[TBL] [Abstract][Full Text] [Related]
39. Preliminary evidence for associations between second-trimester human chorionic gonadotropin and unconjugated oestriol levels with pregnancy outcome in Down syndrome pregnancies.
Benn PA
Prenat Diagn; 1998 Apr; 18(4):319-24. PubMed ID: 9602476
[TBL] [Abstract][Full Text] [Related]
40. Maternal and neonatal characteristics associated with neonatal neutropenia in hypertensive pregnancies.
Sharma G; Nesin M; Feuerstein M; Bussel JB
Am J Perinatol; 2009 Oct; 26(9):683-9. PubMed ID: 19670129
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
